Protandim supplement anti-drug causes Surge in Stock Price for parent company Lifevantage Corporation: In beneath than a 30 day period, the banal amount of the Lifevantage Corporation (LFVN) rose by over 19% based on some changes in administration and lath of directors. The banal which currently resides at about a dollar and a bisected is still a acceptable buy according to analysts based on the achievement of its primary product, Protandim.
Protandim is a comestible supplement which has been clinically accurate to abate the furnishings of oxidative stress, as able-bodied as the accelerating amount of cellular crumbling according to the company. Secondary to the Protandim is LifeVantage TrueScience Anti-Aging Cream.
LifeVantage, comestible supplement aggregation which currently holds four patents for Protandim, is reportedly aswell researching and developing articles to abode such issues as distance sickness, derma cancer, photo crumbling of the skin, renal failure, osteoarthritis, HIV/AIDS-associated lipodystrophy, pulmonary hypertension, periodontal disease, affection disease, coronary avenue bypass affix failure, asthma, Duchenne able-bodied dystrophy, metabolic syndrome, non-alcoholic blubbery alarmist disease, and optic neuropathy.
Lifevantage captivated its anniversary shareholders affair on January 10th. The after-effects of the meeting, which included abacus four new lath members, appears to be what has spurred the contempo access in banal prices.
According to advice appear by the company, the new lath aggregate afterwards the actor affair and appointed Woody Spedden as the new Chairman of the Board.
Q2 banking after-effects for LFVN are accepted to be appear afterwards the abutting on Valentines Day next week. Just a few months ago the aggregation added its 2012 fincal angle adage that it expects revenues of $95-$105 actor against antecedent estimates of $80 to $90 million. Similarly operating assets projections were aswell aloft by about $3-$5 million.
Protandim is a comestible supplement which has been clinically accurate to abate the furnishings of oxidative stress, as able-bodied as the accelerating amount of cellular crumbling according to the company. Secondary to the Protandim is LifeVantage TrueScience Anti-Aging Cream.
LifeVantage, comestible supplement aggregation which currently holds four patents for Protandim, is reportedly aswell researching and developing articles to abode such issues as distance sickness, derma cancer, photo crumbling of the skin, renal failure, osteoarthritis, HIV/AIDS-associated lipodystrophy, pulmonary hypertension, periodontal disease, affection disease, coronary avenue bypass affix failure, asthma, Duchenne able-bodied dystrophy, metabolic syndrome, non-alcoholic blubbery alarmist disease, and optic neuropathy.
Lifevantage captivated its anniversary shareholders affair on January 10th. The after-effects of the meeting, which included abacus four new lath members, appears to be what has spurred the contempo access in banal prices.
According to advice appear by the company, the new lath aggregate afterwards the actor affair and appointed Woody Spedden as the new Chairman of the Board.
Q2 banking after-effects for LFVN are accepted to be appear afterwards the abutting on Valentines Day next week. Just a few months ago the aggregation added its 2012 fincal angle adage that it expects revenues of $95-$105 actor against antecedent estimates of $80 to $90 million. Similarly operating assets projections were aswell aloft by about $3-$5 million.
No comments:
Post a Comment